secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2023-02-24T23:59:59+00:00
Accession:  0000914475-23-000016
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine closes collaboration with Voyager; pays $136M upfront, buys $39M in stock
--------------------------------------------------------------------------------

- Collaboration Agreement with Voyager became effective Feb 21, 2023 after HSR waiting period expired.
- Neurocrine paid Voyager ~$136M upfront and purchased 4,395,588 shares at $8.88/share for ~$39M.
- Jude Onyia, Neurocrine's CSO, appointed to Voyager's board per Amended Investor Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447523000016/0000914475-23-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447523000016/nbix-20230221.htm
  HTML page:      https://secwatch.observer/filing/0000914475-23-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer